We serve Triallylamine CAS:102-70-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Use:Used in organic synthesis and resin modification, also used as a cross-linking agent for superabsorbents, intermediates of ion exchange resins.
| Analysis Contents | Specification | Analysis result |
| Appearance | Colorless transparent liquid | Conforms |
| Assay | ≥99% | 99.07% |
| Moisture | ≤0.2% | 0.12% |
| Boiling point | 150OC | Conforms |
| Conclusion | Conforms | |
Contact us for information like Triallylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N,N-triallylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propen-1-amine, N,N-di-2-propenyl- Use and application,2-Propen-1-amine, N,N-di-2-propenyl- technical grade,usp/ep/jp grade.
Related News: In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.Urea, formaldehyde, diethylenetriamine, triethylenetetramine, melamine resin manufacturer Global Times reported that local officials had been putting up slogans in an effort to get communities to stay at home during the epidemic and to avoid people gathering together to slow and prevent the spread of the coronavirus.L-Norleucine supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.3-Methoxy-17α-methyl-oestratrien-(2.5(10).15)-ol-(17β) vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.
